Drug information for NIMOTOP
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
30MG
Discontinued
NIMODIPINE
Nimodipine
BAYER PHARMS
18869
2006-01-31 Healthcare Professional Sheet
2006-01-30 Letter
2006-01-27 Label
2000-08-22 Letter
2000-08-22 Label
Drug Adverse Effects information for NIMOTOP
Role code
Indications
Reaction
# Reports
C
ANXIETY
COELIAC DISEASE
2
C
ANXIETY
DIARRHOEA
2
C
ASTHMA
CEREBRAL HAEMORRHAGE
1
C
ASTHMA
CEREBROVASCULAR ACCIDENT
1
C
ASTHMA
CONFUSIONAL STATE
1
C
ASTHMA
DISORIENTATION
1
C
ASTHMA
HAEMORRHAGIC TRANSFORMATION STROKE
1
C
ASTHMA
IMMOBILE
1
C
DEPRESSION
COELIAC DISEASE
2
C
DEPRESSION
DIARRHOEA
2
C
GASTRITIS
EMBOLISM
1
C
GASTRITIS
HAEMATOMA
1
C
GASTRITIS
HEMIPLEGIA
1
C
GASTRITIS
UNDERDOSE
1
C
HYPERSENSITIVITY
COELIAC DISEASE
2
C
HYPERSENSITIVITY
DIARRHOEA
2
C
HYPERTENSION
CEREBRAL HAEMORRHAGE
1
C
HYPERTENSION
CEREBROVASCULAR ACCIDENT
1
C
HYPERTENSION
COELIAC DISEASE
4
C
HYPERTENSION
CONFUSIONAL STATE
1
C
HYPERTENSION
DIARRHOEA
4
C
HYPERTENSION
DISORIENTATION
1
C
HYPERTENSION
HAEMORRHAGIC TRANSFORMATION STROKE
1
C
HYPERTENSION
IMMOBILE
1
C
PARKINSON'S DISEASE
COELIAC DISEASE
8
C
PARKINSON'S DISEASE
DIARRHOEA
8
C
PRODUCT USED FOR UNKNOWN INDICATION
CEREBRAL HAEMORRHAGE
3
C
PRODUCT USED FOR UNKNOWN INDICATION
CEREBROVASCULAR ACCIDENT
3
C
PRODUCT USED FOR UNKNOWN INDICATION
CONFUSIONAL STATE
3
C
PRODUCT USED FOR UNKNOWN INDICATION
DISORIENTATION
3
C
PRODUCT USED FOR UNKNOWN INDICATION
HAEMORRHAGIC TRANSFORMATION STROKE
3
C
PRODUCT USED FOR UNKNOWN INDICATION
IMMOBILE
3
C
THROMBOSIS PROPHYLAXIS
EMBOLISM
1
C
THROMBOSIS PROPHYLAXIS
HAEMATOMA
1
C
THROMBOSIS PROPHYLAXIS
HEMIPLEGIA
1
C
THROMBOSIS PROPHYLAXIS
UNDERDOSE
1
Ads by Google